Approved medicine
KPV is not in this lane
As of September 2026, no FDA-approved KPV product or official KPV drug label exists.
Where KPV stands
KPV is small. The unknowns are not.
KPV is a peptide, which means a short chain of protein building blocks. KPV’s chain has only three links. Their chemical names are lysine, proline and valine, and their one-letter codes, K, P and V, give KPV its name.
As of September 2026, FDA has approved KPV for no use at all in the United States.
No study has tested KPV in a living person. That leaves both benefit and side effects unknown.
Open the source notes for this answer
The main record is a report FDA staff wrote for a July 2026 meeting about KPV. To double-check, we also searched FDA’s list of approved drugs and the US register of clinical trials. Neither lists KPV.
FDA staff report on KPV (July 2026) FDA’s list of approved drugs US clinical-trial register: search for KPVClaim versus evidence
Why online interest runs ahead of the research
Online pages attach KPV to gut health, inflammation, wounds, skin, and other goals. Those claims have not been tested in people.
What looks hopeful
Cells and mice showed less inflammation
In human cells grown in a lab dish, KPV turned down the chemical signals that drive inflammation, the body’s swelling-and-redness response. Mouse studies of bowel inflammation also found less inflammation and earlier weight recovery.
That work helps researchers form a question. It does not answer whether KPV helps a person.
Lab result ≠ human result
A cell dish can show a possible action. An animal study can show what happened in that animal. Neither tells us the benefits, harms, or useful form in people.
What is missing
No one has been studied taking KPV
FDA reviewers found no study in people and no report of anyone taking KPV in any form, whether as a shot, a pill, a cream or a spray.
That is why a confident promise about results is doing more work than the evidence can carry.
The missing human research is the main point
There is no human result to compare with a sales claim. A careful conversation starts there.
Open the research trail
The bowel findings came from cells and mice, not from people.
Cell and mouse study of bowel inflammation, in a gut-medicine journal Second mouse study of bowel inflammation Search of PubMed, the US medical-research library, for human studiesThree things that sound alike
A mention online is not the same as medical approval
An approved medicine, a medicine a pharmacy mixes to order, and a product sold “for research” are different things. Check which one is on offer, and what exactly is being promised.
Made-to-order medicine
Compounding does not create approval
In compounding, a pharmacist or doctor prepares a single patient's medicine by hand, rather than a drug company turning out a finished, packaged product. A compounded drug, as of September 2026, carries no FDA approval, and nobody at FDA reviews its quality, safety, or effect before it reaches the market.
Withdrawn request
This is not a green light
FDA's page, last updated April 22, 2026, shows KPV as nominated but withdrawn. That means a pharmacy group had asked FDA to let pharmacies use KPV, then took the request back. That status is not approval or clearance.
Research label
This is not a way to get care
As of September 2026, an item sold only for research is not a lawful way to get treatment.